Editorial
NHS cost efficiencies: biosimilars to the rescue?
Drug and Therapeutics Bulletin · 2026-05 · 64 (5) · 66-67
DOI: 10.1136/dtb.2025.000027 ↗Kurz gefasst
Editorial in der Zeitschrift Drug and Therapeutics Bulletin, online erschienen am 19.03.2026. Verfasst von Michael Wilcock und 1 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacy, Royal Cornwall Hospitals NHS Trust, Truro, UK mike.wilcock@nhs.net. Die Arbeit nennt 13 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
PharmacyPrimary Health CareSecondary Care
Autor:innen und Institutionen
- Pharmacy, Royal Cornwall Hospitals NHS Trust, Truro, UK mike.wilcock@nhs.net.
- Medicines Optimisation Team, NHS Cornwall and the Isles of Scilly ICB, Bodmin, Cornwall, UK.
Zitieren
APA
Wilcock, M., & Motta, M. (2026). NHS cost efficiencies: biosimilars to the rescue?. Drug and Therapeutics Bulletin, 64(5), 66-67. https://doi.org/10.1136/dtb.2025.000027
Vancouver
Wilcock M, Motta M. NHS cost efficiencies: biosimilars to the rescue?. Drug and Therapeutics Bulletin. 2026;64(5):66-67. doi:10.1136/dtb.2025.000027
BibTeX
@article{Wilcock2026,
author = {Wilcock, Michael and Motta, Marco},
title = {NHS cost efficiencies: biosimilars to the rescue?},
journal = {Drug and Therapeutics Bulletin},
year = {2026},
volume = {64},
number = {5},
pages = {66--67},
doi = {10.1136/dtb.2025.000027}
}
EUVIMED